Alessandro D'aveni

Bergamo, 24125, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Avelumab Treatment in Very Elderly People With Advanced Merkel Cell Carcinoma: A Case Report and Review of the Literature.

Avelumab Treatment in Very Elderly People With Advanced Merkel Cell Carcinoma: A Case Report and Review of the Literature.

Journal: Cureus

Published: November 24, 2025

Advanced-stage ALK-positive non-small-cell lung cancer (NSCLC) patients: Real-world treatment patterns and outcomes from the Italian biomarker ATLAS database.

Advanced-stage ALK-positive non-small-cell lung cancer (NSCLC) patients: Real-world treatment patterns and outcomes from the Italian biomarker ATLAS database.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: September 16, 2025

Braf-mutant metastatic non-small-cell lung cancer: Real world data from the Italian biomarker atlas database.

Braf-mutant metastatic non-small-cell lung cancer: Real world data from the Italian biomarker atlas database.

Journal: European journal of cancer (Oxford, England : 1990)

Published: June 02, 2025

Final results of DIADEM, a phase II study to investigate the efficacy and safety of durvalumab in advanced pretreated malignant pleural mesothelioma.

Final results of DIADEM, a phase II study to investigate the efficacy and safety of durvalumab in advanced pretreated malignant pleural mesothelioma.

Journal: ESMO open

Published: April 27, 2022

Treating disease progression with osimertinib in EGFR-mutated non-small-cell lung cancer: novel targeted agents and combination strategies.

Treating disease progression with osimertinib in EGFR-mutated non-small-cell lung cancer: novel targeted agents and combination strategies.

Journal: ESMO open

Published: May 12, 2021

Salvage radiotherapy for oligo-progressive malignant pleural mesothelioma.

Salvage radiotherapy for oligo-progressive malignant pleural mesothelioma.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: August 03, 2020

Immune checkpoint inhibitors in SARS-CoV-2 infected cancer patients: the spark that ignites the fire?

Immune checkpoint inhibitors in SARS-CoV-2 infected cancer patients: the spark that ignites the fire?

Journal: Lung cancer (Amsterdam, Netherlands)

Published: April 30, 2020

Pulmonary Arterial Hypertension in ALK Receptor Tyrosine Kinase-Positive Lung Cancer Patient: Adverse Event or Disease Spread?

Pulmonary Arterial Hypertension in ALK Receptor Tyrosine Kinase-Positive Lung Cancer Patient: Adverse Event or Disease Spread?

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: October 12, 2018

Liquid biopsy for lung cancer early detection.

Liquid biopsy for lung cancer early detection.

Journal: Journal of thoracic disease

Published: May 22, 2018

Osimertinib in the treatment of non-small-cell lung cancer: design, development and place in therapy.

Osimertinib in the treatment of non-small-cell lung cancer: design, development and place in therapy.

Journal: Lung Cancer (Auckland, N.Z.)

Published: September 02, 2017

Spotlight on ceritinib in the treatment of ALK+ NSCLC: design, development and place in therapy.

Spotlight on ceritinib in the treatment of ALK+ NSCLC: design, development and place in therapy.

Journal: Drug design, development and therapy

Published: July 26, 2017

Showing 1-11 of 11

Last Updated: 09/26/2026